Rising cases in several world hot spots are worsening an uneven rollout of COVID-19 vaccine, both in developed countries and in lower income countries who for now depend on initial supplies from the COVAX program.For example, amid India's surge of cases, country health officials are leaning on more vaccine supply from its own Serum Institute, one of the few producers supplying vaccine for deliveries to lower and middle-income countries through COVAX.
And in Europe, where cases are spiking in many countries, the European Union (EU) continues to discuss export controls as a way to prop up already-low supplies for member countries.WHO issues urgent appeal for 10 million dosesYesterday, the World Health Organization (WHO) warned about delays in